New and Effective Inhibitor of Class I HDACs, Eimbinostat, Reduces the Growth of Hematologic Cancer Cells and Triggers Apoptosis

<b>Background:</b> Histone deacetylases (HDACs) are critical epigenetic modulators involved in regulating various molecular mechanisms essential for cell development and growth. Alterations in HDAC activity have been linked to the progression of numerous cancers, including lymphoma. Over...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Pavel Spirin, Valeria Vedernikova, Tatsiana Volkava, Alexey Morozov, Alla Kleymenova, Anastasia Zemskaya, Lena Shyrokova, Yuri Porozov, Ksenia Glumakova, Timofey Lebedev, Maxim Kozlov, Vladimir Prassolov
Format:	Article
Language:	English
Published:	MDPI AG 2025-03-01
Subjects:	epigenetic HDACs belinostat lymphoma leukemia apoptosis
Online Access:	https://www.mdpi.com/1999-4923/17/4/416